Search Results
136 items found for "Wnt pathway inhibition"
- Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone
< GPCR News < GPCRs in Oncology and Immunology Wnt pathway inhibition with the porcupine inhibitor LGK974 The Wnt signaling pathway has been implicated in the pathogenesis of FD-like bone, but the specific Wnts Treatment with the porcupine inhibitor LGK974, which blocks Wnt signaling broadly, induced partial resorption in a mouse model of Gs-GPCR pathway overactivation." pathway inhibition , fibrotic bone disease , fibrous dysplasia (FD) , osteoblasts , trabecular bone
- Ep 92 with Dr. Stephane Angers
Moon , where he identified and characterized novel components of the Wnt signaling pathway and a new His research program is developed to understand the signaling mechanisms underlying the Wnt and Hedgehog His pioneer work led to the development of novel antibody molecules blocking and activating the Wnt pathway
- GPR56 signaling pathway network and its dynamics in the mesenchymal transition of glioblastoma
< GPCR News < GPCRs in Oncology and Immunology GPR56 signaling pathway network and its dynamics in the mining of the molecular events plausibly associated with GPR56 activity, we have constructed a signaling pathway , integrin, calcium signaling, growth factors, and inflammation signaling pathways. We also considered intracellular and extracellular factors that may influence the activity of the pathway Raksha A Ganesh , Krishnan Venkataraman , Ravi Sirdeshmukh Tags GPR56 /ADGRG1 , Mesenchymal transition , Pathway
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
collecting duct specific GPR56 knockout mice Jianxiang Xue Anti-Tumorigenic Role of Brain Angiogenesis Inhibitor Jianxiang Xue on the web Zaidman Physiology Lab Anti-Tumorigenic Role of Brain Angiogenesis Inhibitor University of Alabama at Birmingham" About Virginea de Araujo Farias "Brain Angiogenesis Inhibitor (BAI WNT pathway activation in WNT-MB is driven by mutations of the CTNNB1 gene, activating ß-catenin-dependent signaling; however, no interactions between BAI3 and the WNT signaling pathway have been described so
- Transcriptomic analysis of human cytomegalovirus to survey the indirect effects on renal transplant recipients
Methods: To investigate the activated biological pathways in HCMV infection, total RNA was extracted Afterward, Gene Ontology (GO) and pathway enrichment analyses were conducted to determine the enriched pathways and biological processes by DEGs. KEGG pathway analysis revealed the enrichment of DEGs in IL18 signaling, AGE-RAGE signaling pathway in and signaling by Wnt due to HCMV infection.
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
< GPCR News < GPCRs in Oncology and Immunology GPR68-ATF4 signaling is a novel prosurvival pathway in of GPR68 named Ogremorphin (OGM) to induce the iron mediated cell death pathway: ferroptosis. survival assays, via nuclei counting and cell titer glo, were used to demonstrate sensitivity to GPR68 inhibition To determine GPR68 inhibition's mechanism of cell death we use DAVID pathway analysis of RNAseq. In this context, GPR68 suppresses ATF4, inhibition of GPR68 increases expression of ATF4 which leads
- RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway
Immunology RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway Published date March 2, 2024 Abstract " Background: Novel therapeutic Furthermore, Transcriptome sequencing was performed to show enrichment genes and pathways. Remarkably, inhibiting Hippo signaling with GA-017 promoted cell proliferation and activated autophagy Conclusion: Our findings indicate that RGS20 drives NSCLC cell proliferation by triggering autophagy via the inhibition
- Ep 46 with Dr Gunnar Schulte
focus in the Schulte lab is on Frizzled signaling and pharmacology aiming to understand the role of WNT Most importantly my research team tries to understand underlying mechanisms of WNT-receptor interaction
- Session VII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Session VII Physiological and pathological roles of AGPCRs in the nervous system Uncovering the signaling pathway Remoulade in Drosophila Beatriz Blanco Redondo The Adhesion GPCR Latrophilin Interacts With The Notch Pathway To Control Germ Cell Proliferation Willem Berend Post Uncovering the signaling pathway of the ADGRA We also aimed at identifying the signaling pathway that Remo is involved in. Remo may serve a role in this peculiar signaling pathway and require further analysis."
- Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production by inhibiting activation of pAKT pathways in primary T cells
Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production by inhibiting activation of pAKT pathways in primary T cells Published date June 12, 2023 Abstract "T cell antigen Interestingly, stimulation of hM3Dq resulted in reduced pAKT and its downstream pathway. Moreover, an inhibitor of PI3K reduced IL-2 production in TCR-stimulated hM3Dq/β1 CD4 T cells, suggesting that activating the pAKT pathway is critical for IL-2 production in T cells."
- Dynamic Phosphoproteomics of BRS3 Activation Reveals the Hippo Signaling Pathway for Cell Migration
in Oncology and Immunology Dynamic Phosphoproteomics of BRS3 Activation Reveals the Hippo Signaling Pathway revealed that 27 phosphopeptides corresponding to six proteins were involved in the Hippo signaling pathway Verification experiments demonstrated that downregulation of the Hippo signaling pathway caused by BRS3 Yes-associated protein (YAP), and its association with cell migration was further confirmed by kinase inhibition demonstrate that BRS3 activation contributes to cell migration through downregulation of the Hippo signaling pathway
- Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer cell proliferation by enhancing the ERK pathway
intestinal peptide receptor 2 signaling promotes breast cancer cell proliferation by enhancing the ERK pathway Treatment with KS-133, a VIPR2-selective antagonist peptide, significantly inhibited VIP-induced cell cAMP and phosphorylated extracellular signal-regulated kinase (ERK), which involves a VIPR2 signaling pathway Moreover, an inhibitor of mitogen-activated protein kinase kinase, U0126, attenuated tumor proliferation these findings suggest that VIPR2 controls breast tumor growth by regulating the cAMP/PKA/ERK signaling pathway
- Unveiling Non-Canonical Functions for Gαq Signaling Pathways
Sponsors GPCR Retreat Program < Back to schedule Unveiling Non-Canonical Functions for Gαq Signaling Pathways Ribas has characterized the existence of a new signaling pathway with a relevant role in cardiac hypertrophy
- Activation of PI3K/Akt pathway by G protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell lung cancer
< GPCR News < GPCRs in Oncology and Immunology Activation of PI3K/Akt pathway by G protein-coupled receptor As a member of the GPCR family, G protein-coupled receptor 37 (GPR37) exhibits unknown functions in tumors cisplatin, and affects tumor formation and growth. (3) GPR37 activates PI3K/Akt/mTOR signal transduction pathways Knockdown of GPR37 significantly inhibits the occurrence and development of NSCLC. , Jing Jie , Shucheng Hua , Xiaoxue Bai , Shuai Wang , Lei Song Tags EMT , GPR37 , NSCLC , PI3K/Akt pathway
- Context-dependent ciliary regulation of hedgehog pathway repression in tissue morphogenesis
< GPCR News < GPCRs in Oncology and Immunology Context-dependent ciliary regulation of hedgehog pathway In the hedgehog pathway, bifunctional GLI transcription factors generate both GLI-activators (GLI-A) However, how these counterregulatory effectors coordinate cilia-regulated morphogenetic pathways is unclear Here we determined GLI-A/GLI-R requirements in phenotypes arising from lack of hedgehog pathway repression We studied hedgehog pathway repression by the GPCR GPR161, and the ankyrin repeat protein ANKMY2 that
- CaaX-motif-adjacent residues influence G protein gamma (Gγ) prenylation under suboptimal conditions
Pharmacological inhibition of the lipid synthesis pathway by statins is a therapeutic approach to control Building on our previous finding that statins inhibit membrane association of G protein γ (Gγ) in a subtype-dependent manner, we investigated the molecular reasoning for this differential inhibition. the failure of using prenyltransferase inhibitors in cancer treatment." Waruna Thotamune , John L Payton , Ajith Karunarathne Tags HMG-CoA reductase , cholesterol , mevalonate pathway
- Full Agenda for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
PM Mexico City Nocturnal Tour, Food and drinks Read More Oct 24 - 9:00 AM Session II AGPCR signaling pathways Regions of a Holo-Adhesion GPCR Virginea de Araujo Farias Anti-Tumorigenic Role of Brain Angiogenesis Inhibitor with GPR110 Deletion Júlia Rosell Tethered Agonist Dependent ADGRL3 Signaling Activity In The G12/13 Pathway Adhesion GPCRs GPR110 and GPR116 Willem Berend Post The Adhesion GPCR Latrophilin Interacts With The Notch Pathway characterization of a non-cleavable point mutant knock-in mouse, H381S Jesse Stillwell Next Generation MBD2 inhibitors
- Glucose and HODEs regulate Aspergillus ochraceus quorum sensing through the GprC-AcyA pathway
and Immunology Glucose and HODEs regulate Aspergillus ochraceus quorum sensing through the GprC-AcyA pathway Here we show that the G protein-coupled receptor (GPCR) to cAMP pathway is responsible for transmitting Moreover, the GprC that classified as sugar sensor, and intracellular adenylate cyclase (AcyA)-cAMP-PKA pathway These studies highlight a crucial G protein signaling pathway for cell communication that is mediated
- Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Inhibition in monogenic autoinflammatory disorders and the autoimmune adverse effect resulting from checkpoint inhibitors Rottapel’s research interests lies in the elucidation of signal transduction pathways in cancer, immune observed in ovarian cancer and the identification of emergent vulnerabilities associated with adaptation pathways
- Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation
Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway mutations, and our experiments confirmed oncogenic CysLT2R was impaired at activating the FAK/YAP/TAZ pathway our bioinformatic analysis uncovers a role for co-occurring mutations involving the plexin/semaphorin pathway , which has been shown capable of activating this pathway.
- Ep 146 with Dr Michael Feigin
SUNY Stony Brook studying the role of G-protein coupled receptors (GPCRs) and their regulators in the Wnt signaling pathway. in vivo work, and Mike explained that he wanted to use better models to understand cancer signaling pathways Cytokine Inhibition, Collaboration, and Anti-Anxiety Drug Research Mike discussed the ongoing research on a drug that inhibits cytokine synthesis, its potential in killing cancer cells, and the team's efforts
- Systems Pharmacodynamic Model of Combination Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways
Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways Published date October 31, 2023 Abstract related to cell growth and migration, specifically the RTK-, integrin-, GPCR-, and calcium-signaling pathways Here we describe drug effects on pathways associated with cell cycle, DNA damage response (DDR), and Drug combination effects on protein changes in the cell cycle- and apoptosis pathways contribute to the
- GPR97 depletion aggravates imiquimod-induced psoriasis pathogenesis via amplifying IL-23/IL-17 axis signal pathway
depletion aggravates imiquimod-induced psoriasis pathogenesis via amplifying IL-23/IL-17 axis signal pathway Particularly, we found that level of NF-κB p65 was increased in GPR97-/- DCs and BDP could inhibit p65
- Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia
Mechanistic studies revealed that 8GL treatment inhibits the activation of the mammalian target of rapamycin (mTOR), a regulator of AML cell differentiation blockade, via activating GPR132-Gs-PKA pathway. We further showed that the combination of 8GL and an mTOR inhibitor synergistically elicited AML cell Importantly, 8GL alone or in combination with an mTOR inhibitor remarkably impaired tumor growth and
- DANGER Signals Activate G-Protein Receptor Kinases Suppressing Neutrophil Function and Predisposing to Infection After Tissue Trauma
GRK2 inhibitors like paroxetine restore functions. Actin polymerization, CTX, bacterial phagocytosis and killing were also rescued therefore by the HDAC inhibitor Either GRK2 or HDAC inhibition prevented loss of mouse lung bacterial clearance, but only the combination DAMPs suppress antimicrobial immunity via canonical GRK2 activation and a novel TLR-activated GRK2 pathway Simultaneous GRK2/HDAC inhibition rescues susceptibility to infection after tissue injury.
- Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration
Synergistic effects on calcium flux and cell migration are inhibited by the Gαi inhibitor pertussis toxin and the Gαq inhibitor YM254890, suggesting that the Gαi and Gαq pathways are involved in the synergy
- "Have a nice weekend, and I'll see you tomorrow!": RAMP-interacting GPCR Pathways
: RAMP-interacting GPCR Pathways Date & Time Thursday, November 2nd / 4:30 PM Keynote Talk Abstract Coming
- A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P1 signaling axis
enhancing signaling mediated by sphingosine-1-phosphate (S1P), a bioactive lipid that stimulates oncogenic pathways CHK1 and the transcriptional regulators cMYC and STAT3 and by increasing the abundance of cancerous inhibitor Inhibition of S1P signaling abrogated the proliferative and anti-apoptotic effects of US28.